Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Bristol-Myers Squibb discovers new ribosome-inactivating protein

March 27, 1997

Multikine trial approved in Israel

March 21, 1997

Immunogen terminates Oncolysin development

March 20, 1997

Cel-Sci purchases complete rights to Multikine

March 11, 1997

AltaRex receives funding for clinical trials on Ovarex

March 10, 1997

IDEC and Roche submit applications for IDEC-C2B8

March 5, 1997

ONYX expands ONYX-015 clinical trials

March 4, 1997

Roche's Roferon-A receives EU approval

March 4, 1997

IGG's MMS-1 covered by patent

March 3, 1997

Immunotherapy cancer vaccine in phase II

Feb. 20, 1997